Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 358 results for "sun pharmaceutical industries"

Pharmerging Markets 2016-2020
Global Information Inc

Recently Research on Protein Therapeutics Market 2016 2015 Ana...

Market outlook of the pharmerging markets Technavios research analyst predicts the pharmerging markets to grow steadily at a CAGR of 13% during the forecast period. The increase in public and private healthcare insurance is the primary growth ... Franklin Credit Management Corporation, 5 hours ago
Pharmerging Markets 2016-2020 Global Information Inc, 16 hours ago
A month of correction for pharma stocks Financial Chronicle, 1 week ago

16 images for sun pharmaceutical industries

DNA India, 5 days ago
Sify, 3 weeks ago
Reuters, 2 weeks ago
Reuters, 3 weeks ago
India Infoline, 1 week ago
India Infoline, 1 week ago
Financial Express, 5 days ago
Business Standard India, 1 week ago
Business Standard India, 3 weeks ago
First, 3 weeks ago

India's mega pharma event CPhI & P-MEC India begins in Mumbai

The three-day CPhI and P-MEC India, South Asia's largest pharma event, began at Bombay Convention and Exhibition Centre, Mumbai which will witness participation from over 97 countries, 1100 exhibitors and 32000 delegates. As the global demand for ...
 PharmaBiz14 hours ago UBM India Launches CPhI & P-MEC India 2015  PR Newswire India8 hours ago

Best and worst performing stocks in 2015

Pharma, infotech, FMCG and textile firms lead; interest rate sensitives like banks, realty, capital goods and infra remain laggards. Mid-cap stocks stole the show yet another time in 2015, after a stellar show last year, too. With bears continuing to rule the broader markets and sentiments not yet positive, some large-cap stocks have delivered abysmal returns. For instance, take the health care sector, where the winds have not been in favour of large-cap companies such as Dr Reddy's and Sun ...
 Rediff.com1 day ago Mid-caps again steal the show  Business Standard India2 days ago

Takeda to unload off-patent sales to focus on new drugs

TOKYO -- Takeda Pharmaceutical will gradually transfer sales operations for off-patent drugs to a joint venture with Israeli generics titan Teva Pharmaceutical Industries as part of efforts to focus on new drugs. The top drugmaker in Japan ...
 Nikkei Asian Review1 day ago

Sun Pharma: Valuations factor in the downsides

Related to : Sun Pharmaceuticals Industries Ltd Sun Pharmaceuticals Industries Ltd BSE 30 Nov 15 | 12:00 AM 730.65 -9.3 (-1.26%) NSE 30 Nov 15 | 12:00 AM 729.65 -10.2 (-1.38%) Sun Pharma has shed about 40 per cent of its market ...
 Smart Investor1 day ago
DNA India

Sun Pharma drops wind energy plan; shares rise over 4%

The shares of Sun Pharmaceutical Industries gained as much as 4.5% on Thursday after the company on Tuesday announced that its subsidiaries were contemplating an investment in a wind energy project in the US, but that the subsidiaries had later ...
 DNA India5 days ago Sun Pharma gains as Taro drops wind energy investment  Smart Investor5 days ago Sun Pharma up 2%, Taro decides not to invest in wind energy  Moneycontrol.com5 days ago Sun Pharma gains after aborting wind energy investment  Hindu Business Line5 days ago

Sun Pharma gains after subsidiaries cancel wind energy project investment in US

Sun Pharmaceutical Industries jumped 4.11% to Rs 737 at 15:45 IST on BSE after the company said that after a further evaluation, some of the company's subsidiaries have decided not to proceed with investment in a wind energy project in the US. ...
 Capital Market5 days ago Sun Pharmaceutical Industries updates on subsidiaries  Capital Market1 week ago BioLight Announces Joint Investment in IOPtima Subsidiary  FierceMedicalDevices2 hours ago BioLight Reports Third Quarter 2015 Financial Results  Crawford Financial Planning10 hours ago
Calcutta Telegraph

Pharma frets over US generic trend

Mumbai, Nov. 29: The domestic pharmaceutical sector, which is already facing challenges such as increased scrutiny from the US Food and Drugs Administration (FDA), slower drug approvals and price erosion, is likely to confront more difficulties over ...
 Calcutta Telegraph2 days ago
Business Standard India

Indian pharma companies face payment issues in Venezuela

Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged the central government to work out a medicines for oil barter arrangement with Venezuela. The proposal has been made as foreign exchange (forex) controls in Venezuela have ...
 Smart Investor3 days ago

Taro Pharma drops plan to invest in Suzlon's US power project

MUMBAI: Taro Pharmaceutical Industries, a global subsidiary of India's largest drug maker Sun Pharmaceutical, has dropped its plan to invest in a wind power project in the United States just four days after announcing the $250-million investment. ...
 Economic Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharmaceutical industries
Get updated on latest news & your favorite topics right in your inbox!
More     Less